Evidence map›Paper›PMID 23089861›Full record

ReviewNature chemistry2012

Heterogeneities of individual catalyst particles in space and time as monitored by spectroscopy.

Inge L C Buurmans, Bert M Weckhuysen

Abstract readReview
PubMed Publisher
In one paragraph

Review in Nature chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 104 papers.

0numbers the graph read from it
0cells of the map it votes in
104citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

104 citing papers in PubMed.

  1. Concluding remarks:Faraday discussions · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Revealing operando surface defect-dependent electrocatalytic performance of Pt at the subparticle level.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  18. Review
  19. Review
  20. Following the dynamics of industrial catalysts under operando conditions.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article

44 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Inge L C BuurmansInorganic Chemistry and Catalysis Group, Debye Institute for NanoMaterials Science, Faculty of Science, Utrecht University, Universiteitsweg 99, 3584 CG Utrecht, The Netherlands.
Bert M Weckhuysen

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent years have witnessed the introduction of spatiotemporal spectroscopy for the characterization of catalysts at work at previously unattainable resolution and sensitivity. They have revealed that heterogeneous catalysts are more heterogeneous than often expected. Dynamic changes in the nature of active sites, such as their distribution and accessibility, occur both between and within particles. Scientists now have micro- and nanospectroscopic methods at hand to improve the understanding of catalyst heterogeneities and exploit them in catalyst design. Here we review the latest developments within this lively field. The trends include detection of single particles or molecules, super-resolution imaging, the transition from two- to three-dimensional imaging, selective staining, integration of spectroscopy with electron microscopy or scanning probe methods, and measuring under realistic reaction conditions. Such experimental approaches change the hitherto somewhat static picture of heterogeneous catalysis into one that acknowledges that catalysts behave almost like living objects--explaining why many characterization methods from the life sciences are being incorporated into catalysis research.

Indexed as

CatalysisNanoparticlesOxidesPorositySpatio-Temporal AnalysisSpectrum AnalysisOxides

Identifiers

PMID23089861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.